Publication | Open Access

Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome

MedicinePharmacological AgentClinical PharmacologyZollinger-ellison SyndromePharmacotherapyPharmacologyDrug Discovery